Dr Zsolt Herberth, MD | |
555 Willard Ave, Newington, CT 06111-2631 | |
(860) 666-6951 | |
Not Available |
Full Name | Dr Zsolt Herberth |
---|---|
Gender | Male |
Speciality | Internal Medicine - Nephrology |
Location | 555 Willard Ave, Newington, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811092711 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 39949 (Kentucky) | Secondary |
207RN0300X | Internal Medicine - Nephrology | ME 103591 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Zsolt Herberth, MD 555 Willard Ave, Newington, CT 06111-2631 Ph: (860) 666-6951 | Dr Zsolt Herberth, MD 555 Willard Ave, Newington, CT 06111-2631 Ph: (860) 666-6951 |
News Archive
In a case study that illustrates the need for people with diabetes to be cautious of foot injuries and to protect themselves from pets, a woman with numbness in her feet caused by diabetic neuropathy slept through a traumatic episode in which her Jack Russell terrier chewed off part of her slightly infected big toe, according to an article published in this month's issue of the Journal of the American Podiatric Medical Association.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
An analysis of genetic and clinical data for nearly 800 patients with non-small cell lung cancer has identified differences in genetic characteristics that are associated with age and sex specific patterns of increased or decreased recurrence-free survival, according to a study in the February 10 issue of JAMA.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new pre-clinical data from its hypercholesterolemia program, performed in collaboration with scientists at the University of Texas Southwestern Medical Center at Dallas. The data were presented at the PCSK9 Conference: From Gene to Therapeutics held in Nantes, France from March 11-13, 2010.
› Verified 1 days ago
Jeffrey Mark Kagan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 365 Willard Ave, Suite 2-d, Newington, CT 06111 Phone: 860-665-1571 Fax: 860-667-3668 | |
Dr. Donald J Curran, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 555 Willard Ave, Newington, CT 06111 Phone: 860-594-6393 Fax: 860-667-6875 | |
Dr. Shahnaz Hussain, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 18 Cedar St, Newington, CT 06111 Phone: 860-667-1244 Fax: 860-666-5153 | |
Alla Turshudzhyan, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 555 Willard Ave, Newington, CT 06111 Phone: 866-808-7921 | |
Zied Gaifer Ali, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 372 Cypress Rd, Newington, CT 06111 Phone: 703-919-7279 | |
Dr. Akhilesh Kumar Singh, MD Nephrology Medicare: Medicare Enrolled Practice Location: 555 Willard Ave, Newington, CT 06111 Phone: 860-666-6951 | |
Sarah Finnegan, MD Nephrology Medicare: Medicare Enrolled Practice Location: 555 Willard Ave, Newington, CT 06111 Phone: 866-808-7921 |